Additionally, a recent investigation suggests that a quantitative analysis of the liver function by contrast-enhanced ultrasonography (CEUS) in conjunction with a quantitative analysis of the SALL4/Wnt/β-catenin axis expression may serve as an early diagnosis method for HCC patients [176]. The gene discussed is SALL4; the disease is hepatocellular carcinoma.